SIRT2 Protein May Be Blood Marker of Parkinson’s That Differs from Atypical Parkinsonian Syndromes, Study Says

SIRT2 Protein May Be Blood Marker of Parkinson’s That Differs from Atypical Parkinsonian Syndromes, Study Says
High levels of a protein called SIRT2 in the blood may serve as a diagnostic biomarker to differentiate between Parkinson’s patients and those with atypical Parkinson syndromes, a study finds. Levels of this marker also may aid in diagnosing Parkinson’s at early stages. The study, “Elevated Serum SIRT 2 May Differentiate Parkinson’s Disease From Atypical Parkinsonian Syndromes,” was published in the ... read more
Source: Parkinson’s News TodayPublished on 2019-07-03By Iqra Mumal